Skip to main content

Biolog Granted $250,000 SBIR for Phenotype MicroArray Platform

NEW YORK, June 9 - Biolog has received a Phase I Small Business Innovation Research grant of $250,000 from the National Cancer Institute for a project using its Phenotype MicroArray assay platform in toxicological cell-based assays, the company said today.

 

The grant will support development of the technology for use with human and mouse cell lines. It is currently used with bacteria, yeast, and filamentous fungi.

 

According to Biolog, the technology can be used to determine the effect of genetic changes on cells and to determine the effect of drugs on cells.

The Scan

Pfizer-BioNTech Seek Full Vaccine Approval

According to the New York Times, Pfizer and BioNTech are seeking full US Food and Drug Administration approval for their SARS-CoV-2 vaccine.

Viral Integration Study Critiqued

Science writes that a paper reporting that SARS-CoV-2 can occasionally integrate into the host genome is drawing criticism.

Giraffe Species Debate

The Scientist reports that a new analysis aiming to end the discussion of how many giraffe species there are has only continued it.

Science Papers Examine Factors Shaping SARS-CoV-2 Spread, Give Insight Into Bacterial Evolution

In Science this week: genomic analysis points to role of human behavior in SARS-CoV-2 spread, and more.